tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Alnylam reports Q3 EPS $1.84, consensus $1.75
PremiumThe FlyAlnylam reports Q3 EPS $1.84, consensus $1.75
14h ago
ALNY Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
ALNY Upcoming Earnings Report: What to Expect?
3d ago
Alnylam Pharmaceuticals: Strong Market Performance and Promising Pipeline Drive Buy Rating
Premium
Ratings
Alnylam Pharmaceuticals: Strong Market Performance and Promising Pipeline Drive Buy Rating
3d ago
Alnylam and Regeneron Join Forces in Promising Alzheimer’s Study
PremiumCompany AnnouncementsAlnylam and Regeneron Join Forces in Promising Alzheimer’s Study
21d ago
Alnylam price target raised to $475 from $405 at Morgan Stanley
Premium
The Fly
Alnylam price target raised to $475 from $405 at Morgan Stanley
25d ago
Alnylam price target raised to $495 from $441 at Stifel
Premium
The Fly
Alnylam price target raised to $495 from $441 at Stifel
25d ago
Alnylam price target raised to $500 from $435 at RBC Capital
PremiumThe FlyAlnylam price target raised to $500 from $435 at RBC Capital
1M ago
Alnylam price target raised to $520 from $453 at BofA
Premium
The Fly
Alnylam price target raised to $520 from $453 at BofA
1M ago
Alnylam Pharma: Promising Growth Driven by ATTR-CM Franchise and siRNA Platform Expansion
Premium
Ratings
Alnylam Pharma: Promising Growth Driven by ATTR-CM Franchise and siRNA Platform Expansion
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100